Neurotrophin Expression in Lymphocytes: a Powerful Indicator of Degeneration in Parkinson’s Disease, Amyotrophic Lateral Sclerosis and Ataxia

Improving drug delivery technology for treating neurodegenerative diseases

(2016) Yahya E. Choonara et al.   Expert Opinion on Drug Delivery

Phytochemicals That Regulate Neurodegenerative Disease by Targeting Neurotrophins: A Comprehensive Review

(2015) Ramu Venkatesan et al.   Biomed Research International

GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein

(2014) J J Credle et al.   CELL DEATH AND DIFFERENTIATION

Nitric Oxide-Mediated Oxidative Damage and the Progressive Demise of Motor Neurons in ALS

(2012) Derek A. Drechsel et al.   NEUROTOXICITY RESEARCH

Why are the neurodegenerative disease-related pathways overrepresented in primary HIV-infected peripheral blood mononuclear cells: a genome-wide perspective

(2012) Li Zhou et al.   Virology Journal

Peripheral Assessment of the Genes AQP4, PBP and TH in Patients with Parkinson’s Disease

(2011) S. Thamizh Thenral et al.   NEUROCHEMICAL RESEARCH

Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease

(2010) M.T. Armentero et al.   NEUROBIOLOGY OF AGING

Targeting Neurotrophin Receptors in the Central Nervous System

(2008) Italo Mocchetti et al.   CNS & Neurological Disorders-Drug Targets

Brain‐derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood‐derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/Akt‐dependent signaling pathways

(2008) Jung Yeon Lim et al.   JOURNAL OF NEUROSCIENCE RESEARCH